ARK Genomic Revolution ETF (BATS:ARKG) Shares Sold by US Bancorp DE

US Bancorp DE lessened its holdings in shares of ARK Genomic Revolution ETF (BATS:ARKG) by 13.9% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 5,710 shares of the company’s stock after selling 921 shares during the quarter. US Bancorp DE’s holdings in ARK Genomic Revolution ETF were worth $134,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Hemington Wealth Management boosted its position in shares of ARK Genomic Revolution ETF by 44.6% during the 4th quarter. Hemington Wealth Management now owns 1,310 shares of the company’s stock valued at $30,000 after acquiring an additional 404 shares during the last quarter. Union Bancaire Privee UBP SA acquired a new position in shares of ARK Genomic Revolution ETF during the 4th quarter valued at about $45,000. National Bank of Canada FI boosted its position in shares of ARK Genomic Revolution ETF by 28.4% during the 3rd quarter. National Bank of Canada FI now owns 4,155 shares of the company’s stock valued at $106,000 after acquiring an additional 920 shares during the last quarter. ARK Investment Management LLC boosted its position in shares of ARK Genomic Revolution ETF by 72.7% during the 4th quarter. ARK Investment Management LLC now owns 5,989 shares of the company’s stock valued at $141,000 after acquiring an additional 2,521 shares during the last quarter. Finally, IHT Wealth Management LLC acquired a new position in shares of ARK Genomic Revolution ETF during the 3rd quarter valued at about $203,000.

ARK Genomic Revolution ETF Price Performance

Shares of ARKG stock opened at $22.76 on Monday. The company’s 50-day moving average price is $25.75 and its 200-day moving average price is $25.16. ARK Genomic Revolution ETF has a twelve month low of $21.56 and a twelve month high of $31.16.

ARK Genomic Revolution ETF Profile

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.